YTE reported $18.5B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Agenus AGEN:US $ 1.22B 664.46M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Cerulean Pharma CERU:US $ 93.27M 13.31M
Chemocentryx CCXI:US $ 933.95M 2.64B
Clovis Oncology CLVS:US $ 606.48M 127.32M
Cti Biopharma CTIC:US $ 233.21M 29.15M
Eli Lilly And LLY:US $ 220.12B 40.96B
Exelixis EXEL:US $ 5.71B 1.36B
Gilead Sciences GILD:US $ 86.36B 4.99B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Idera Pharmaceuticals IDRA:US $ 60.04M 457.74K
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Macrogenics MGNX:US $ 1.62B 176.65M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Moderna Inc MRNA:US $ 94.35B 41.95B
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Newlink Genetics NLNK:US $ 83.57M 13.91M
Novartis NOVN:VX 208.02B 8.76B
Novartis NVS:US 224.91B 13.69B
Pfizer PFE:US $ 219205.69M 17108.81M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M